Premium
αv vitronectin receptors in vascular‐mediated disorders
Author(s) -
Mousa Shaker A.
Publication year - 2003
Publication title -
medicinal research reviews
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.868
H-Index - 130
eISSN - 1098-1128
pISSN - 0198-6325
DOI - 10.1002/med.10031
Subject(s) - vitronectin , receptor , medicine , pharmacology , chemistry , integrin
Various integrin antagonist candidates including antibodies, cyclic peptides, peptidomimetics, and non‐peptides have been clinically evaluated and shown to successfully modulate certain disease processes. This review will focus on the key role of the αv integrin (αvβ3 and αvβ5) in vascular disorders such as restenosis and angiogenesis‐mediated disorders. © 2002 Wiley Periodicals, Inc. Med Res Rev, 23, No. 2, 190–199, 2003